foscarnet sodium · Clinigen Hlthcare · NDA 020068
Foscavir
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220068, Caplin · 020068-001Approved 13 May 2026Detected 25 Oct 2026Historical import
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020068 · 001 · RLD | solution, intravenous | 6GM/250ML (24MG/ML) | open |
| 020068 · 002 · RLD · discontinued | solution, intravenous | 12GM/500ML (24MG/ML) | open |